Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Esophageal Squamous Cell Carcinoma 4 Pancreatic Neoplasms 2 NSCLC 2 Carcinoma, Squamous Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 PFS 1 Neoplasms 1 NRG1-fused Non-small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Focus of Study Instead 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Colorectal Neoplasms 1 Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Focus of Study Instead × Afatinib × Clear all

NCT01728818 2017-07-19

ACCEPT

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Focus of Study Instead

Data powered by HemOnc (CC BY 4.0) Colophon ⚡